Panacea Biotec Hits Upper Circuit Limit Amid Strong Market Interest and Liquidity
Panacea Biotec Ltd has reached its upper circuit limit, with a notable intraday high and significant gains over the past week. The stock has shown strong market interest, robust liquidity, and is trading above multiple moving averages, reflecting its positive momentum in the pharmaceuticals sector.
Panacea Biotec Ltd, a small-cap player in the Pharmaceuticals & Drugs industry, has made headlines today by hitting its upper circuit limit. The stock reached an intraday high of Rs 549.05, marking a significant increase of 4.99% from the previous close. This surge comes as the company has shown consistent performance, gaining 25.83% over the last five days and outperforming its sector by 4.55% today.The stock opened with a notable gain of 2.78%, reflecting strong market interest. With a total traded volume of approximately 0.90152 lakh shares and a turnover of Rs 4.89 crore, Panacea Biotec has demonstrated robust liquidity, supported by a delivery volume that surged by 313.01% compared to its five-day average.
Currently, Panacea Biotec is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong upward trend. The stock's performance today reinforces its position in the market, as it continues to attract attention from investors. Overall, Panacea Biotec's recent activity highlights its positive momentum within the pharmaceuticals sector.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
